Methylation of the serotonin transporter gene moderates the depressive subjective effect of cocaine
- PMID: 34798166
- PMCID: PMC8671356
- DOI: 10.1016/j.bbr.2021.113675
Methylation of the serotonin transporter gene moderates the depressive subjective effect of cocaine
Abstract
Genetic variation in the serotonin transporter (SLC6A4) has been shown to moderate the acute subjective effects of cocaine. Methylation of the SLC6A4 gene is associated with decreased transcription of the serotonin transporter, leading to increased serotonin in the synapse. In this study, methylation of the SLC6A4 gene was investigated in the moderation of the subjective effects of cocaine. Non-treatment-seeking cocaine-dependent individuals (N = 53) were intravenously administered cocaine (40 mg) and saline in a randomized order. The subjective effects of cocaine were self-reported using a visual analog scale starting prior to the administration of cocaine (-15 min) or saline and up to 20 min after infusion. Participants were evaluated for methylation of the SLC6A4 promoter region and 5-HTTLPR genotype. A series of ANCOVAs for SLC6A4 methylation (high/low) were run for each of ten subjective and three cardiovascular effects controlling for age, sex [utilizing the sex-determining region Y protein (SRY)], and population structure (determined from ancestry informative markers and STRUCTURE software). Participants with SLC6A4 hypermethylation reported greater subjective response to cocaine for 'depressed' relative to participants with SLC6A4 hypomethylation (experiment-wise p = 0.002). These findings indicate that SLC6A4 methylation moderates the 'depressed' subjective effect of cocaine in non-treatment-seeking cocaine-dependent participants.
Keywords: Cocaine; Epigenetics; Methylation; Serotonin.
Published by Elsevier B.V.
Conflict of interest statement
Conflicts of interest
None.
Figures
References
-
- SAMHSA, Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55), in: S.A.a.M.H.S. Administration (Ed.) Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD, 2020.
-
- Molander AC, Mar A, Norbury A, Steventon S, Moreno M, Caprioli D, Theobald DE, Belin D, Everitt BJ, Robbins TW, Dalley JW, High impulsivity predicting vulnerability to cocaine addiction in rats: some relationship with novelty preference but not novelty reactivity, anxiety or stress, Psychopharmacology (Berl) 215(4) (2011) 721–731. - PubMed
-
- Gawin FH, Khalsa-Denison ME, Is craving mood-driven or self-propelled? Sensitization and “street” stimulant addiction, NIDA Res Monogr 163 (1996) 224–250. - PubMed
-
- Dackis CA, O’Brien CP, Cocaine dependence: a disease of the brain’s reward centers, J Subst Abuse Treat 21(3) (2001) 111–117. - PubMed
-
- Kendler KS, Jacobson KC, Prescott CA, Neale MC, Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins, Am J Psychiatry 160(4) (2003) 687–695. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
